Based on recent data, Minerva Neurosciences, Inc. (NERV) shows an Average True Range (ATR) of 0.5 and an Enterprise Value of 58.63M. Its average trading volume over the past 3 months is 222.51K, indicating liquidity. These fundamental metrics provide insight into NERV's underlying financial health and market activity.
| ATR | 0.5 |
| Enterprise Value | 58.63M |
| Avg Vol (3 Months) | 222.51K |
| Avg Vol (10 Days) | 155.13K |
Minerva Neurosciences, Inc. (NERV) technical indicators as of July 30, 2026: the SMA 20 is 10.28%, SMA 50 at 30.76%, and SMA 200 at 102.56%. The RSI 14 value is 67.11, suggesting its current momentum. These technical analysis signals help assess NERV's price trends and potential future movements.
| SMA 20 | 10.28% |
| SMA 50 | 30.76% |
| SMA 200 | 102.56% |
| RSI 14 | 67.11 |
Minerva Neurosciences, Inc. (NERV) stock performance overview as of July 30, 2026: The 52-week high is $12.46 (currently -50% below), and the 52-week low is $1.76 (currently 441.74% above). Over the past year, NERV's performance is 104.22%, compared to the S&P 500's 3.8% change.
| 52-Week High | 12.46 |
| 52-Week High Chg | -50.00% |
| 52-Week Low | 1.76 |
| 52-Week Low Chg | +441.74% |
| S&P 500 52-Week Chg | 3.8% |
According to market data, Minerva Neurosciences, Inc. (NERV) stock's recent performance metrics show that over the last month, NERV is 15%, with a Year-to-Date (YTD) performance of 8.71%. Over the past year, the stock has seen a 104.22% change. These figures summarize NERV's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 4.48 | 5.55 | 6.63 | 8.8 | 12.46 | 8.8 |
| Low | 3.95 | 3.94 | 3.94 | 3.75 | 1.76 | 3.75 |
| Performance | +1.16% | +15.00% | +75.50% | +125.15% | +104.22% | +8.71% |
According to current financial data, NERV stock's P/E (TTM) ratio is -0.14, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for NERV, including P/S (N/A), P/B (-0.69), and P/FCF (-0.01), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | NERV | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.14 | -1.24 | -194.78 | 32.59 |
| P/S (TTM) | N/A | 3.7 | 468.69 | 5.98 |
| P/B (TTM) | -0.69 | 3.31 | -3496.45 | 5.51 |
| P/FCF (TTM) | -0.01 | 371.92 | -643.48 | 31.19 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep